Bernick Brian

Co-Chief Executive OfficerTherapeuticsMD, Inc. (TXMD) · full profile →Form 4 · filed Dec 9, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$7K
Net Open-Market Flow
-$7K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 9, 2022Sell(S)320$6.31$2K4K
Dec 6, 2022Option exercise(M)3K$05K
Dec 6, 2022Sell(S)935$4.92$5K4K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 6, 2022Option exercise(M)3K$011K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-060588) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.